This HTML5 document contains 174 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n8http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n12https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q26829564
rdf:type
wikibase:Item
schema:description
vědecký článek publikovaný v roce 2012 мақолаи илмӣ наукова стаття, опублікована в червні 2012 2012年論文 บทความทางวิทยาศาสตร์ مقالهٔ علمی artículo científico publicado en 2012 2012年論文 article científic scientific article articol științific wissenschaftlicher Artikel artikull shkencor 2012年论文 2012년 논문 2012 թուականի Յունիսին հրատարակուած գիտական յօդուած מאמר מדעי videnskabelig artikel (udgivet 2012-06) ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ mokslinis straipsnis 2012年の論文 teaduslik artikkel tudományos cikk научная статья artigo científico 2012年论文 articolo scientifico (pubblicato il 2012-06) 2012年论文 naučni članak vitskapeleg artikkel article scientifique (publié 2012-06) مقالة علمية (نشرت في يونيو 2012) 2012年论文 სამეცნიერო სტატია 2012 թվականի հունիսին հրատարակված գիտական հոդված scienca artikolo 2012年論文 artykuł naukowy artikulong pang-agham artículu científicu espublizáu en 2012 vitenskapelig artikkel tieteellinen artikkeli 2012年論文 vedecký článok (publikovaný 2012-06) artigo científico (publicado na 2012) мақолаи илмӣ artigo científico (publicado na 2012-06) 2012年論文 научни чланак bilimsel makale wetenschappelijk artikel (gepubliceerd in 2012-06) научни чланак article scientific επιστημονικό άρθρο 2012年论文 2012 nî lūn-bûn bài báo khoa học سائنسی مضمون vetenskaplig artikel научна статия 2012年论文
p:P577
wds:Q26829564-C11C2715-506D-4095-9F9C-3E8CFEEDAA1A wds:Q26829564-58897AE1-551C-40D6-9949-862CB35DA7F8
wdt:P577
2012-06-01T00:00:00Z
p:P407
wds:Q26829564-9AD0A44A-1FFC-4F4C-9BEE-4F6B67696E11
wdt:P407
wd:Q1860
p:P2888
wds:Q26829564-1538F879-68CD-4177-B281-8923E5F6AD01
wdt:P2888
n12:s10194-012-0428-7
p:P2860
wds:Q26829564-56301A55-C3A1-47B6-8C74-F53F0D3AD5E8 wds:Q26829564-59272C74-B55A-4284-AA6B-41A9160378C5 wds:Q26829564-64303A30-4D95-4828-BDBC-92128A138C71 wds:Q26829564-67C222CB-6F5C-4B57-AC25-11DCB64CEC30 wds:Q26829564-789C97FF-9D27-44B8-9FC5-436554B26A24 wds:Q26829564-9E92BECB-5093-4C16-A820-B9032C87AF9F wds:Q26829564-AEC36D34-B17E-40AA-BD92-4ED910C7767A wds:Q26829564-B33AC2C7-4FFB-4ED7-ACBC-D316558F43D9 wds:Q26829564-C5166679-4B61-4268-A2D6-ED2D5E5A8F44 wds:Q26829564-DE36634D-8C1A-4F68-96E7-CE8C84388F63 wds:Q26829564-E4F49F78-B096-4C9D-8337-87B5BC1B52B1 wds:Q26829564-FACA249D-ED42-4C89-BDD5-4E478B65223E wds:Q26829564-FB2A465F-B132-4A81-B77B-CC2FE6B1DE00 wds:Q26829564-01A9691A-4BF6-431C-B08E-E4C31102F7D5 wds:Q26829564-0FBBAD0E-8C8E-4756-BF5E-F7015C6F9243 wds:Q26829564-173487B6-C55C-459F-8C2C-7422723A220A wds:Q26829564-2607AC34-6BF7-4964-9916-C89F0E38C323 wds:Q26829564-45ADFC5A-9577-4C5A-9DEE-A2F872DF008B
wdt:P2860
wd:Q42081184 wd:Q37606694 wd:Q37357042 wd:Q34155864 wd:Q37808726 wd:Q34099102 wd:Q42541071 wd:Q39408073 wd:Q38004483 wd:Q64410891 wd:Q45018129 wd:Q42882661 wd:Q83514663 wd:Q34304867 wd:Q34987743 wd:Q34127399 wd:Q38499621 wd:Q45024230
rdfs:label
The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials
skos:prefLabel
The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials
schema:name
The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials
p:P50
wds:Q26829564-5FEC1EB8-FA47-40AA-BBB5-F9FE896095DE wds:Q26829564-56DE6053-D25A-4E79-A22F-351385D7B5AB
wdt:P50
wd:Q29643374 wd:Q78649226
p:P1476
wds:Q26829564-FB63AF46-3483-4E1C-81A6-7CEAE7AC3B62
wdt:P1476
The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials
p:P304
wds:Q26829564-D425D93D-1409-4982-9D12-F4C8B2BC2D16
wdt:P304
271-5
p:P31
wds:Q26829564-6DE11F7B-01C0-452C-A5E2-08ADFE3DF5DF wds:Q26829564-5FACEEE1-7769-4B4E-8B3E-CFC8741FA0DA
wdt:P31
wd:Q7318358 wd:Q13442814
p:P921
wds:Q26829564-7B0E3069-A3B0-483B-8610-7749EFC8269F wds:Q26829564-6972B54D-B745-427D-992A-A5B3CD1F4BAF wds:Q26829564-5E0A4A81-4EF5-4F32-BDFE-BD7F3CAFDD80 wds:Q26829564-F1824F3D-80C9-4172-A198-ED641050C542 wds:Q26829564-C51EB329-926E-4F26-91C0-C470FC01AE0C wds:Q26829564-9db9fb98-453b-2efb-b4ab-8edc591d4370 wds:Q26829564-47234B32-6D2C-4336-920B-16604DC695D1 wds:Q26829564-4bb26ffc-491c-4ba8-0912-b26577ff8a78 wds:Q26829564-2FE824F0-68CF-4B3E-9736-4B96B62A607C wds:Q26829564-13B045F1-FF1D-4028-8DEA-84E9AC643EEB wds:Q26829564-FC3CEB52-9005-418F-8BF6-2669D138C16C
wdt:P921
wd:Q188777 wd:Q193430 wd:Q269829 wd:Q43648 wd:Q66648976 wd:Q134856 wd:Q133823 wd:Q3271540 wd:Q6493750 wd:Q47317020 wd:Q42824440
p:P698
wds:Q26829564-36828A8B-CC44-48F8-897B-AAC2D1BB0B11
wdtn:P698
n13:22430431
wdt:P698
22430431
p:P1433
wds:Q26829564-DA6179BC-817F-4700-AA97-C9DE040D0F35
wdt:P1433
wd:Q26842211
p:P433
wds:Q26829564-7722D624-199F-456F-9514-77EFF685661D
p:P478
wds:Q26829564-086D0101-7373-4C8C-A6E2-AFE7D5FF9140
wdt:P433
4
wdt:P478
13
p:P356
wds:Q26829564-3B0B5620-45C5-4BDB-A6E1-8C8BE61E187C
wdtn:P356
n8:S10194-012-0428-7
wdt:P356
10.1007/S10194-012-0428-7
p:P275
wds:Q26829564-CB4D56A6-0DC8-4940-85F0-C47087223160 wds:Q26829564-ee33edc3-a6df-4f00-8d1e-17e4475a34c5
p:P6216
wds:Q26829564-f3566174-44b7-4de2-bdf9-eb308dd57102
wdt:P275
wd:Q19125117 wd:Q20007257
wdt:P6216
wd:Q50423863
p:P8608
wds:Q26829564-B30BBBD4-9204-466D-AF6D-8B9ADB7496EF
wdt:P8608
release_zrz7b2vax5ejzl7qgsnimr55py
p:P5875
wds:Q26829564-E244ADF1-9709-4E63-A1F5-0C61148EE6C3
wdt:P5875
221723088
p:P6179
wds:Q26829564-710A7A95-4E9E-4908-9E4B-8CA65022B8F5
wdt:P6179
1024179636
p:P932
wds:Q26829564-E275D364-1068-45DD-B4DC-C00F9320BEB7
wdt:P932
3356470